Takeda Pharmaceutical (TAK) Goodwill & Intangibles (2018 - 2026)

Takeda Pharmaceutical's Goodwill & Intangibles history runs 9 years deep, the most recent figure standing at $58.8 billion for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles changed 0.24% year-over-year to $58.8 billion in Q1 2026; TTM through Mar 2026 was $58.8 billion, a 0.24% change from a year earlier, with the FY2026 full-year figure at $61.3 billion, up 4.27% from the prior year.
• Goodwill & Intangibles declined to $58.8 billion in Q1 2026 per TAK's latest filing, from $60.2 billion in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $70.8 billion in Q1 2022 and bottomed at $58.7 billion in Q1 2025.
• The 5-year median for Goodwill & Intangibles is $62.3 billion (2024), against an average of $63.8 billion.
• Across the five-year window, Goodwill & Intangibles declined 14.52% in 2022 and grew 4.07% in 2023, its largest moves.
• Year by year, Goodwill & Intangibles stood at $59.9 billion in 2022, then advanced by 4.07% to $62.3 billion in 2023, then gained by 0.04% to $62.3 billion in 2024, then decreased by 3.35% to $60.2 billion in 2025, then declined by 2.3% to $58.8 billion in 2026.
• Per Business Quant, the three latest TAK Goodwill & Intangibles figures stand at $58.8 billion (Q1 2026), $60.2 billion (Q4 2025), and $59.3 billion (Q3 2025).